VimRx, Ribonetics Gmbh deal

VMRX purchased Ribonetics for $1.5 million in cash, warrants to purchase 365,000 to 500,000 shares of VMRX, and a 10 percent interest in the VMRX subsidiary that will own the Ribonetics technology. In...